Biological processes associated with breast cancer clinical outcome depend on the molecular subtypes.


Autoria(s): Desmedt C.; Haibe-Kains B.; Wirapati P.; Buyse M.; Larsimont D.; Bontempi G.; Delorenzi M.; Piccart M.; Sotiriou C.
Data(s)

2008

Identificador

http://serval.unil.ch/?id=serval:BIB_A3E6728DEE31

isbn:1078-0432 (Print)

pmid:18698033

doi:10.1158/1078-0432.CCR-07-4756

isiid:000258523800020

Idioma(s)

en

Fonte

Clinical Cancer Research, vol. 14, no. 16, pp. 5158-5165

Palavras-Chave #Breast Neoplasms/genetics; Breast Neoplasms/metabolism; Female; Gene Expression; Humans; Kaplan-Meier Estimate; Prognosis; Receptor, erbB-2; Receptors, Estrogen/biosynthesis
Tipo

info:eu-repo/semantics/article

article